EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Arcturus Therapeutics Holdings Inc. (ARCT) had EBITDA Margin of -45.11% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$166.80M |
|
$-29.73M |
|
-- |
|
$166.80M |
|
$245.00M |
|
$-78.20M |
|
$50.31M |
|
$-27.89M |
|
$-27.89M |
|
$-29.73M |
|
$-29.73M |
|
$-29.73M |
|
$-29.73M |
|
$-78.20M |
|
$-75.25M |
|
26.63M |
|
26.63M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$386.59M |
|
$12.43M |
|
$42.81M |
|
$429.40M |
|
$81.99M |
|
-- |
|
$68.90M |
|
$150.89M |
|
$278.51M |
|
$278.51M |
|
$278.51M |
|
26.83M |
|
| Cash Flow Statement Financials | |
$-18.10M |
|
$-2.90M |
|
$-24.09M |
|
$393.98M |
|
$348.89M |
|
$-45.09M |
|
$34.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-46.89% |
|
-46.89% |
|
|
EBITDA Margin |
-45.11% |
-16.72% |
|
-17.82% |
|
$-21.00M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
-- |
|
5.20 |
|
70.16 |
|
-10.67% |
|
-10.67% |
|
-6.92% |
|
-10.67% |
|
$10.38 |
|
$-0.79 |
|
$-0.68 |
|